Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation ; volume:15 ; number:1 ; day:19 ; month:11 ; year:2015 ; pages:1-7 ; date:12.2015
BMC cardiovascular disorders ; 15, Heft 1 (19.11.2015), 1-7, 12.2015
- Creator
-
Abumuaileq, Rami Riziq-Yousef
Abu-Assi, Emad
López-López, Andrea
Raposeiras-Roubin, Sergio
Rodríguez-Mañero, Moisés
Martínez-Sande, Luis
García-Seara, Javier
Fernandez-López, Xesús Alberte
Peña-Gil, Carlos
González-Juanatey, Jose Ramón
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-015-0149-3
- URN
-
urn:nbn:de:101:1-2019080819101447772530
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abumuaileq, Rami Riziq-Yousef
- Abu-Assi, Emad
- López-López, Andrea
- Raposeiras-Roubin, Sergio
- Rodríguez-Mañero, Moisés
- Martínez-Sande, Luis
- García-Seara, Javier
- Fernandez-López, Xesús Alberte
- Peña-Gil, Carlos
- González-Juanatey, Jose Ramón
- SpringerLink (Online service)
Other Objects (12)
Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation
Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation
Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation
Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation